Procedural fairness in benefit package design: inclusion of pre-exposure prophylaxis of HIV in Universal Coverage Scheme in Thailand.

Shaheda Viriyathorn, Saranya Sachdev, Waraporn Suwanwela, Waritta Wangbanjongkun, Walaiporn Patcharanarumol, Viroj Tangcharoensathien
Author Information
  1. Shaheda Viriyathorn: International Health Policy Program (IHPP), Ministry of Public Health, Tiwanon Road, Nonthaburi 11000, Thailand. ORCID
  2. Saranya Sachdev: International Health Policy Program (IHPP), Ministry of Public Health, Tiwanon Road, Nonthaburi 11000, Thailand.
  3. Waraporn Suwanwela: National Health Security Office (NHSO), The Government Complex Commemorating His Majesty the King's 80th Birthday Anniversary 5th December, B.E.2550 (2007) Building B 120 Moo 3 Chaengwattana Road, Lak Si District, Bangkok 10210, Thailand.
  4. Waritta Wangbanjongkun: International Health Policy Program (IHPP), Ministry of Public Health, Tiwanon Road, Nonthaburi 11000, Thailand.
  5. Walaiporn Patcharanarumol: International Health Policy Program (IHPP), Ministry of Public Health, Tiwanon Road, Nonthaburi 11000, Thailand.
  6. Viroj Tangcharoensathien: International Health Policy Program (IHPP), Ministry of Public Health, Tiwanon Road, Nonthaburi 11000, Thailand.

Abstract

Since 2002, Thailand's Universal Coverage Scheme (UCS) has adopted a comprehensive benefits package with few exclusions. A positive-list approach has gradually been applied, with pre-exposure prophylaxis (PrEP) of HIV recently being included. Disagreements resulting from competing values and diverging interests necessitate an emphasis on procedural fairness when making any decisions. This qualitative study analyses agenda setting, policy formulation and early implementation of PrEP from a procedural fairness lens. Literature reviews and in-depth interviews with 13 key stakeholders involved in PrEP policy processes were conducted. Civil society organizations (CSOs) and academia piloted PrEP service models and co-produced evidence on programmatic feasibility and outcomes. Through a broad stakeholder representation process, the Department of Disease Control proposed PrEP for inclusion in UCS benefits package in 2017. PrEP was shown to be cost-effective and affordable through rigorous health technology assessment, peer review, use of up-to-date evidence and safe-guards against conflicts of interest. In 2021, Thailand's National Health Security Board decided to include PrEP as a prevention and promotion package, free of charge, for the populations at risk. Favourable conditions for procedural fairness were created by Thailand's legislative provisions that enable responsive governance, notably inclusiveness, transparency, safeguarding public interest and accountable budget allocations; longstanding institutional capacity to generate local evidence; and implementation capacity for realisation of procedural fairness criteria. Multiple stakeholders including CSOs, academia and the government deliberated in the policy process through working groups and sub-committees. However, a key lesson from Thailand's deliberative process concerns a possible 'over interpretation' of conflicts of interest, intended to promote impartial decision-making, which inadvertently limited the voices of key populations represented in the decision processes. Finally, this case study underscores the value of examining the full policy cycle when assessing procedural fairness, since some stages of the process may be more amenable to certain procedural criteria than others.

Keywords

References

  1. Lancet. 2018 Mar 24;391(10126):1205-1223 [PMID: 29397200]
  2. BMJ Glob Health. 2021 Feb;6(2): [PMID: 33602688]
  3. J Virus Erad. 2021 May 18;7(2):100042 [PMID: 34141441]
  4. J Virus Erad. 2016 Nov 28;2(Suppl 4):7-14 [PMID: 28275444]
  5. Qual Health Res. 2020 Oct;30(12):1899-1912 [PMID: 32449451]
  6. Pac AIDS Alert Bull. 1999;(18):15-6 [PMID: 12349391]
  7. Health Policy Plan. 1994 Dec;9(4):353-70 [PMID: 10139469]
  8. Health Syst Reform. 2020;6(1):1-7 [PMID: 31567056]
  9. Paediatr Int Child Health. 2017 May;37(2):99-108 [PMID: 28173741]
  10. PLoS One. 2013;8(3):e59549 [PMID: 23527217]
  11. J Int AIDS Soc. 2018 Mar;21(3):e25096 [PMID: 29603888]
  12. Value Health. 2012 Sep-Oct;15(6):961-70 [PMID: 22999148]
  13. Medwave. 2017 Dec 27;17(9):e7117 [PMID: 29286354]
  14. Nat Med. 2021 Jan;27(1):10-13 [PMID: 33340033]
  15. J Int AIDS Soc. 2017 Sep 20;20(1):21744 [PMID: 28953330]
  16. J Adolesc Health. 2020 Jan;66(1):100-106 [PMID: 31757626]
  17. Health Expect. 2020 Dec;23(6):1594-1602 [PMID: 33034411]
  18. Bull World Health Organ. 2020 Feb 1;98(2):117-125 [PMID: 32015582]
  19. Cost Eff Resour Alloc. 2013 Oct 09;11(1):26 [PMID: 24107435]
  20. Euro Surveill. 2019 Jul;24(30): [PMID: 31362808]
  21. Health Policy Plan. 2023 Nov 14;38(Supplement_1):i13-i35 [PMID: 37963078]
  22. Int J Health Policy Manag. 2018 Jul 04;7(11):973-976 [PMID: 30624870]
  23. Int J Infect Dis. 2019 Mar;80:16-27 [PMID: 30529371]
  24. Int J Equity Health. 2020 Sep 21;19(1):163 [PMID: 32958064]
  25. Global Health. 2011 Sep 12;7:32 [PMID: 21910864]
  26. Lancet. 2016 Jan 2;387(10013):53-60 [PMID: 26364263]
  27. Public Health Ethics. 2018 Oct 12;12(1):54-63 [PMID: 30936942]
  28. Lancet Infect Dis. 2018 Jan;18(1):85-94 [PMID: 29054789]
  29. BMJ. 2021 Feb 16;372:n434 [PMID: 33593753]
  30. J Gen Intern Med. 2014 Dec;29(12):1692-701 [PMID: 24893581]
  31. BMJ Glob Health. 2017 Aug 22;2(3):e000342 [PMID: 29082012]
  32. Am J Public Health. 2017 Oct;107(10):1572-1576 [PMID: 28817325]
  33. BMJ. 2021 Feb 15;372:m4669 [PMID: 33593790]
  34. BMC Health Serv Res. 2016 Sep 30;16(1):536 [PMID: 27716185]
  35. Int J STD AIDS. 2013 Oct;24(10):813-21 [PMID: 23970599]
  36. Cult Health Sex. 2016;18(3):249-64 [PMID: 26325239]
  37. Antivir Ther. 2008;13 Suppl 2:109-13 [PMID: 18575199]
  38. Int J Health Policy Manag. 2020 Apr 01;9(4):133-137 [PMID: 32331492]
  39. Health Syst Reform. 2019;5(3):195-208 [PMID: 31407962]

Grants

  1. /Norwegian Institute of Public Health (NIPH)
  2. /Norwegian Institute of Public Health (NIPH)

MeSH Term

Humans
Pre-Exposure Prophylaxis
Thailand
Universal Health Insurance
Delivery of Health Care
HIV Infections

Word Cloud

Created with Highcharts 10.0.0PrEPproceduralfairnessThailand'spackagepolicyprocessprophylaxiskeyevidenceinterestCoverageSchemeUCSbenefitspre-exposurestudyimplementationstakeholdersprocessesCSOsacademiainclusionhealthconflictspopulationscapacitycriteriaSince2002Universaladoptedcomprehensiveexclusionspositive-listapproachgraduallyappliedHIVrecentlyincludedDisagreementsresultingcompetingvaluesdiverginginterestsnecessitateemphasismakingdecisionsqualitativeanalysesagendasettingformulationearlylensLiteraturereviewsin-depthinterviews13involvedconductedCivilsocietyorganizationspilotedservicemodelsco-producedprogrammaticfeasibilityoutcomesbroadstakeholderrepresentationDepartmentDiseaseControlproposed2017showncost-effectiveaffordablerigoroustechnologyassessmentpeerreviewuseup-to-datesafe-guards2021NationalHealthSecurityBoarddecidedincludepreventionpromotionfreechargeriskFavourableconditionscreatedlegislativeprovisionsenableresponsivegovernancenotablyinclusivenesstransparencysafeguardingpublicaccountablebudget allocationslongstandinginstitutionalgeneratelocalrealisationMultipleincludinggovernmentdeliberatedworkinggroupssub-committeesHoweverlessondeliberativeconcernspossible'overinterpretation'intendedpromoteimpartialdecision-makinginadvertentlylimitedvoicesrepresenteddecisionFinallycaseunderscoresvalueexaminingfullcycleassessingsincestagesmayamenablecertainothersProceduralin benefitdesign:of pre-exposureof HIVin Universalin ThailandHIV/AIDSThailanduniversalcoverage

Similar Articles

Cited By